A learning curve of at least 225 procedures is required for hospitals to perform transcatheter aortic valve replacements (TAVRs) with the lowest mortality rates, suggests a study of 16 centers participating in an international registry.

Research out of Denmark suggests diclofenac, the world’s most commonly consumed non-steroidal anti-inflammatory drug (NSAID), poses a major threat to heart health—more so than paracetamol or run-of-the-mill NSAIDs like ibuprofen and naproxen.

The cost of insulin in the U.S. is on the rise, and not all Americans can afford it—a problem one Minnesota mother blames for her son’s death from diabetic ketosis—NPR reported this week.

A population health collaborative in San Diego County contributed to a 22 percent reduction in hospital admissions for acute myocardial infarction (AMI), according to new research published in Health Affairs. Compared to the rest of California—which saw an 8 percent drop in AMI admissions—the program was estimated to prevent nearly 4,000 hospitalizations and save $86 million in its first six years.

Heart attack and stroke patients could minimize their risk of a second infarction by consuming apocynin, an antioxidant close in chemical structure to vanilla, according to research out of Portland, Oregon.

Patients hospitalized with endocarditis can be safely switched from intravenous antibiotics to oral medication about halfway through the course of treatment, according to a randomized trial published in the New England Journal of Medicine.

A new study in the Journal of the American College of Cardiology suggests children born through assisted reproductive technologies (ART) are at an increased risk of developing arterial hypertension early in life.

Lorcaserin was associated with significant weight loss among overweight and obese individuals without compromising cardiovascular safety, according to a large, randomized trial published Aug. 26 in The New England Journal of Medicine and presented at the European Society of Cardiology (ESC) Congress in Munich.